We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
药物 daraxonacib 使胰腺癌患者的生存期翻倍，但无法治愈。了解机制、副作用以及这一突破的实际局限。阅读分析。
